SEARCH

SEARCH BY CITATION

References

  • 1
    Gosepath J, Schafer D, Mann WJ. Aspirin sensitivity: long term follow-up after up to 3 years of adaptive desensitization using a maintenance dose of 100 mg of aspirin a day. Laryngorhinootologie 2002;81:732738.
  • 2
    Stevenson DD. Aspirin sensitivity and desensitization for asthma and sinusitis. Curr Allergy Asthma Rep 2009;9:155163.
  • 3
    Stevenson DD, Szczeklik A. Clinical and pathologic perspectives on aspirin sensitivity and asthma. J Allergy Clin Immunol 2006;118:773786.
  • 4
    Kowalski ML, Makowska JS, Blanca M, Bavbek S, Bochenek G, Bousquet J et al. Hypersensitivity to nonsteroidal anti-inflammatory drugs (NSAIDs) - classification, diagnosis and management: review of the EAACI/ENDA and GA2LEN/HANNA. Allergy 2011;66:818829.
  • 5
    Cheong HS, Park SM, Kim MO, Park JS, Lee JY, Byun JY et al. Genome-wide methylation profile of nasal polyps: relation to aspirin hypersensitivity in asthmatics. Allergy 2011;66:637644.
  • 6
    Palikhe NS, Kim SH, Cho BY, Ye YM, Choi GS, Park HS. Genetic variability in CRTH2 polymorphism increases eotaxin-2 levels in patients with aspirin exacerbated respiratory disease. Allergy 2010;65:338346.
  • 7
    Szczeklik A, Sanak M. The broken balance in aspirin hypersensitivity. Eur J Pharmacol 2006;3:145155.
  • 8
    Baenkler HW. Salicylate intolerance: pathophysiology, clinical spectrum, diagnosis and treatment. Dtsch Arztebl Int 2008;105:137142.
  • 9
    Dobovisek A, Fajmut A, Brumen M. Role of expression of prostaglandin synthases 1 and 2 and leukotriene C4 synthase in aspirin-intolerant asthma: a theoretical study. J Pharmacokinet Pharmacodyn 2011;38:261278.
  • 10
    Schafer D, Lindenthal U, Wagner M, Bolcskei PL, Baenkler HW. Effect of prostaglandin E2 on eicosanoid release by human bronchial biopsy specimens from normal and inflamed mucosa. Thorax 1996;51:919923.
  • 11
    Schäfer D, Maune S. Pathogenic Mechanisms and In Vitro Diagnosis of AERD. J Allergy (Cario) 2012;2012:18.
  • 12
    Lumry WR, Curd JG, Zeiger RS, Pleskow WW, Stevenson DD. Aspirin sensitive rhinosinusitis: the clinical syndrome and effects of aspirin administration. J Allergy Clin Immunol 1983;71:580587.
  • 13
    Gosepath J, Schaefer D, Amedee RG, Mann WJ. Individual Monitoring of Aspirin Desensitization. Arch Otolaryngol Head Neck Surg 2001;127:316321.
  • 14
    Stevenson DD, Hankammer MA, Mathison DA, Christiansen SC, Simon RA. Aspirin desensitization treatment of aspirin-sensitive patients with rhinosinusitis-asthma: long-term outcomes. J Allergy Clin Immunol 1996;98:751758.
  • 15
    Lee JY, Simon RA, Stevenson DD. Selection of aspirin dosages for aspirin desensitization treatment in patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol 2007;119:157164.
  • 16
    Lanas A, Wu P, Medin J, Mills EJ. Low Doses of Acetylsalicylic Acid Increase Risk of Gastrointestinal Bleeding in a Meta-Analysis. Clin Gastroenterol Hepatol 2011;9:762768.
  • 17
    Moberg C, Naesdal J Jr, Svedberg L-E, Duchateau D, Harte N. Impact of gastrointestinal problems on adherence to low-dose acetylsalicylic acid: a quantitative study in patients with cardiovascular risk. Patient 2011;4:103113.
  • 18
    Fokkens WJ, Lund VJ, Mullol J, Bachert C, Alobid I, Baroody F et al. EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. Rhinology 2012;50:112.
  • 19
    Stevenson DD, Sanchez-Borges M, Szczeklik A. Classification of allergic and pseudoallergic reactions to drugs that inhibit cyclooxygenase enzymes. Ann Allergy Asthma Immunol 2001;87:177180.
  • 20
    Schafer D. Testing and typing of eicosanoid-patterns. J Physiol Pharmacol 2006;57(Suppl 12):4764.
  • 21
    Schafer D, Schmid M, Gode U, Baenkler H. Dynamics of eicosanoids in peripheral blood cells during bronchial provocation in aspirin-intolerant asthmatics. Eur Respir J 1999;13:638646.
  • 22
    Lildholdt T, Rundcrantz H, Bende M, Larsen K. Glucocorticoid treatment for nasal polyps: the use of topical budesonide powder, intramuscular betamethasone, and surgical treatment. Arch Otolaryngol Head Neck Surg 1997;123:595600.
  • 23
    Malm L. Assessment and staging of nasal polyposis. Acta Otolaryngol 1997;117:465467.
  • 24
    Wolfensberger M, Schnieper I. Sniffin' Sticks: a new system for olfactory assessment in routine clinical practice. HNO 1999;47:629636.
  • 25
    Maune S, Rudert H, Heissenberg MC, Schmidt C, Eggers S, Landmann K et al. Concepts for measuring quality of life in patients with chronic sinusitis. Laryngorhinootologie 1999;78:475480.
  • 26
    Lund VJ, Kennedy DW. Quantification for staging sinusitis. The Staging and Therapy Group. Ann Otol Rhinol Laryngol Suppl 1995;167:1721.
  • 27
    Lund VJ, Kennedy DW. Staging for rhinosinusitis. Otolaryngol Head Neck Surg 1997;2:3540.
  • 28
    Baker TW, Quinn JM. Aspirin therapy in aspirin-exacerbated respiratory disease: A risk-benefit analysis for the practicing allergist. Allergy Asthma Proc 2011;32:335340.
  • 29
    Rozsasi A, Polzehl D, Deutschle T, Smith E, Wiesmiller K, Riechelmann H et al. Long-term treatment with aspirin desensitization: a prospective clinical trial comparing 100 and 300 mg aspirin daily. Allergy 2008;63:12281234.